Erik Thomas Dustrude

Erik Thomas Dustrude

Auto-generated profile, based on publicly available information

Erik Thomas Dustrude

A Department of Pharmacology, College of Medicine , University of Arizona , Tucson , AZ , USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2017 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
AMAubin Moutal
Aubin Moutal
WLWennan Li
Wennan Li
YWYue Wang
Yue Wang
WJWeina Ju
Weina Ju
SLShizhen Luo
Shizhen Luo
Rajesh KhannaRajesh Khanna
Rajesh Khanna

28 February 2017 in Channels
Verified
Journal Article
Open access
EDErik Thomas Dustrude
Erik Thomas Dustrude
SPSamantha Perez-Miller
Samantha Perez-Miller
LFLiberty François-Moutal
Liberty François-Moutal
AMAubin Moutal
Aubin Moutal
MKMay Khanna
May Khanna
Rajesh KhannaRajesh Khanna
Rajesh Khanna
The neuronal collapsin response mediator protein 2 (CRMP2) undergoes several posttranslational modifications that codify its functions. Most recently, CRMP2 SUMOylation (addition of small ubiquitin like modifier (SUMO)) was identified as a key regulatory step within a modification program that codes for CRMP2 interaction with, and trafficking of, voltage-gated sodium channel NaV1.7. In this paper, we illustrate the utility of combining sequence alignment within protein families with structural analysis to identify, from several putative SUMOylation sites, those that are most likely to be biologically relevant. Co-opting this principle to CRMP2, we demonstrate that, of 3 sites predicted to be SUMOylated in CRMP2, only the lysine 374 site is a SUMOylation client. A reduction in NaV1.7 currents was the corollary of the loss of CRMP2 SUMOylation at this site. A 1.78-Å-resolution crystal structure of mouse CRMP2 was solved using X-ray crystallography, revealing lysine 374 as buried within the CRMP2 tetramer interface but exposed in the monomer. Since CRMP2 SUMOylation is dependent on phosphorylation, we postulate that this state forces CRMP2 toward a monomer, exposing the SUMO site and consequently, resulting in constitutive regulation of NaV1.7.